Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

H19 gene expression is up-regulated exclusively by stabilization of the RNA during muscle cell differentiation

Abstract

H19 is a paternally imprinted gene whose expression produces a 2.4 kb RNA in most tissues during development and in mammalian myoblastic cell lines upon differentiation. Deletion of the active maternal allele of H19 and its flanking regions in the mouse leads to biallelic methylation and loss of imprinting of the neighbouring Igf2 gene. The function of H19 RNA remains unknown and, although polysome-associated, the absence of a conserved open reading frame suggests that it does not encode a protein product. We describe a novel post-transcriptional regulation of H19 gene expression which, in spite of this lack of coding capacity, is dependent on translational activity. We show that stabilization of the RNA is solely responsible for its accumulation during in vitro muscle cell differentiation. This conclusion is based on the finding that inhibition of protein synthesis results in a dramatic destabilization of H19 RNA in proliferating mouse C2C12 myoblastic cells but not in differentiated cells, and on run-on experiments which showed that the rate of transcription of H19 RNA remains constant during muscle cell differentiation. This mechanism could also be involved in H19 gene expression during mouse development in addition to its transcriptional activation which we have shown to occur.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 3
Figure 2
Figure 4

Similar content being viewed by others

References

  • Ainscough JF, Koide T, Tada M, Barton S and Surani MA. . 1997 Development 124: 3621–3632.

  • Barlow DP. . 1997 EMBO J. 16: 6899–6905.

  • Bartolomei MS, Zemel S and Tilghman SM. . 1991 Nature 351: 153–155.

  • Biran H, Ariel I, de Groot N, Shani A and Hochberg A. . 1994 Tumour Biol. 15: 123–134.

  • Brannan CI, Dees EC, Ingram RS and Tilghman SM. . 1990 Mol. Cell. Biol. 10: 28–36.

  • Cui H, Hedborg F, He L, Nordenskjold A, Sandstedt B, Pfeifer-Ohlsson S and Ohlsson R. . 1997 Cancer Res. 57: 4469–4473.

  • Cui H, Horon IL, Ohlsson R, Hamilton SR and Feinberg AP. . 1998 Nat. Med. 4: 1276–1280.

  • Dani C, Blanchard JM, Piechaczyk M, El Sabouty S, Marty L and Jeanteur P. . 1984 Proc. Natl. Acad. Sci. USA 91: 7046–7050.

  • Davis RL, Weintraub H and Lassar AB. . 1987 Cell 51: 987–1000.

  • DeChiara TM, Robertson EJ and Efstratiadis A. . 1991 Cell 64: 849–859.

  • DePonti-Zilli L, Seiler-Tuyns A and Paterson BM. . 1988 Proc. Natl. Acad. Sci. USA 85: 1389–1393.

  • Dugimont T, Montpellier C, Adriaenssens E, Lottin S, Dumont L, Iotsova V, Lagrou C, Stehelin D, Coll J and Curgy JJ. . 1998 Oncogene 16: 2395–2401.

  • Eversole-Cire P, Ferguson-Smith AC, Surani MA and Jones PA. . 1995 Cell Growth Differ. 6: 337–345.

  • Fan XC and Steitz JA. . 1998 Proc. Natl. Acad. Sci. USA 95: 15293–15298.

  • Forné T, Oswald J, Dean W, Saam JR, Bailleul B, Dandolo L, Tilghman SM, Walter J and Reik W. . 1997 Proc. Natl. Acad. Sci. USA 94: 10243–10248.

  • Hao Y, Crenshaw T, Moulton T, Newcomb E and Tycko B. . 1993 Nature 365: 764–767.

  • Hayashida T, Eversole-Cire P, Jones P and Sasaki H. . 1997 J. Biochem. (Tokyo) 122: 901–903.

  • Hibi K, Nakamura H, Hirai A, Fujikake Y, Kasai Y, Akiyama S, Ito K and Takagi H. . 1996 Cancer Res. 56: 480–482.

  • Hurst LD and Smith NG. . 1999 Trends Genet. 15: 134–135.

  • Jones BK, Levorse JM and Tilghman SM. . 1998 Genes Dev. 12: 2200–2207.

  • Joubel A, Curgy JJ, Pelczar H, Begue A, Lagrou C, Stehelin D and Coll J. . 1996 Cell. Mol. Biol. (Noisy-le-grand) 42: 1159–1172.

  • Jouvenot Y, Poirier F, Jami J and Paldi A. . 1999 Curr. Biol. 9: 1199–1202.

  • Juan V, Crain C and Wilson C. . 2000 Nucleic Acids Res. 28: 1221–1227.

  • Junien C. . 1992 Curr. Opin. Genet. Dev. 2: 431–438.

  • Kim DK, Zhang L, Dzau VJ and Pratt RE. . 1994 J. Clin. Invest. 93: 355–360.

  • Ladomery M. . 1997 Bioessays 19: 903–909.

  • Leibovitch MP, Nguyen VC, Gross MS, Solhonne B, Leibovitch SA and Bernheim A. . 1991 Biochem. Biophys. Res. Commun. 180: 1241–1250.

  • Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A and Tilghman SM. . 1995a Nature 375: 34–39.

  • Leighton PA, Saam JR, Ingram RS, Stewart CL and Tilghman SM. . 1995b Genes Dev. 9: 2079–2089.

  • Li X, Adam G, Cui H, Sandstedt B, Ohlsson R and Ekstrom TJ. . 1995 Oncogene 11: 221–229.

  • Li YM, Franklin G, Cui HM, Svensson K, He XB, Adam G, Ohlsson R and Pfeifer S. . 1998 J. Biol. Chem. 273: 28247–28252.

  • Lustig-Yariv O, Schulze E, Komitowski D, Erdmann V, Schneider T, de Groot N and Hochberg A. . 1997 Oncogne 15: 169–177.

  • Mitchell P and Tollervey D. . 2000 Curr. Opin. Genet. Dev. 10: 193–198.

  • Moulton T, Crenshaw T, Hao Y, Moosikasuwan J, Lin N, Dembitzer F, Hensle T, Weiss L, McMorrow L and Loew T. . 1994 Nat. Genet. 7: 440–447.

  • Pachnis V, Belayew A and Tilghmann SM. . 1984 Proc. Natl. Acad. Sci. USA 81: 5523–5527.

  • Pachnis V, Brannan CI and Tilghman SM. . 1988 EMBO J. 7: 673–681.

  • Raynal F, Michot B and Bachellerie JP. . 1984 FEBS Lett. 167: 263–268.

  • Reik W, Brown KW, Slatter RE, Sartori P, Elliot M and Maher ER. . 1994 Hum. Mol. Genet. 3: 1297–1301.

  • Reik W and Walter J. . 1998 Curr. Opin. Genet. Dev. 8: 154–164.

  • Ripoche MA, Kress C, Poirier F and Dandolo L. . 1997 Genes Dev. 11: 1596–1604.

  • Singer C, Rasmussen A, Smith HS, Lippman ME, Lynch HT and Cullen KJ. . 1995 Cancer Res. 55: 2448–2454.

  • Smith CM and Steitz JA. . 1998 Mol. Cell. Biol. 18: 6897–6909.

  • Taniguchi T, Sullivan MJ, Ogawa O and Reeve AE. . 1995 Proc. Natl. Acad. Sci. USA 92: 2159–2163.

  • Thorvaldsen JL, Duran KL and Bartolomei MS. . 1998 Genes Dev. 12: 3693–3702.

  • Tilghman SM. . 1999 Cell 96: 185–193.

  • Tremblay KD, Duran KL and Bartolomei MS. . 1997 Mol. Cell. Biol. 17: 4322–4329.

  • Vacher J, Camper SA, Krumlauf R, Compton RS and Tilghman SM. . 1992 Mol. Cell. Biol. 12: 856–864.

  • Verkerk AJ, Ariel I, Dekker MC, Schneider T, van Gurp RJ, de Groot N, Gillis AJ, Oosterhuis JW, Hochberg AA and Looijenga LH. . 1997 Oncogene 14: 95–107.

  • Wisdom R and Lee W. . 1990 J. Biol. Chem. 265: 19015–19021.

  • Yeilding NM, Procopio WN, Rehman MT and Lee WM. . 1998 J. Biol. Chem. 273: 15749–15757.

  • Yoo-Warren H, Pachnis V, Ingram RS and Tilghman SM. . 1988 Mol. Cell. Biol. 8: 4707–4715.

  • Yun K, Fukumoto M and Jinno Y. . 1996 Am. J. Pathol. 148: 1081–1087.

Download references

Acknowledgements

We thank Dr D Tollervey, Edinburgh, for helpful comments on the manuscript and Dr M Silhol for technical assistance on run-on experiments. This work was supported by grants from the Association pour la Recherche contre le Cancer given to Claude Brunel (contrat 2908), from the Ligue National contre le Cancer given to Claude Brunel and Thierry Forné and the Ligue Nationale contre le Cancer (comité de l'herault) given to Claude Brunel. Laura Milligan was supported by the Fondation pour la Recherche Médicale.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Milligan, L., Antoine, E., Bisbal, C. et al. H19 gene expression is up-regulated exclusively by stabilization of the RNA during muscle cell differentiation. Oncogene 19, 5810–5816 (2000). https://doi.org/10.1038/sj.onc.1203965

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203965

Keywords

This article is cited by

Search

Quick links